🔍 Search
Sign in to post
Amping up T cells to target cancerhttps://www.technologyreview.com/2026/08/25/1140949/amping-up-t-cells-to-target-cancer

Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…

People who live past 110 have an unusual abundance of killer immune cellshttps://www.sciencedaily.com/releases/2026/08/260823014950.htm

People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells. These CD4 cytotoxic T cells became more common with age and often expanded into large groups of nearly identical cells, suggesting the immune system was repeatedly responding to persistent threats.

0trust.social media

Loading your media...

Pick a GIF — Giphy

Loading GIFs...